Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,172,687
-$3,184,297 QoQ
Shares Held
9,282
-70.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,002
of 2,266 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CSM Advisors, LLC holds $167,508,675 across 11 Drug Manufacturers - General names. GILD ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
219,688 | $55,794,161 | |
| 2 | ABBV |
AbbVie Inc.
|
143,403 | $36,085,930 | |
| 3 | LLY |
ELI LILLY & Co
|
27,478 | $32,957,940 | |
| 4 | PFE |
Pfizer Inc
|
889,436 | $21,417,618 | |
| 5 | SNY |
Sanofi
|
360,443 | $15,376,498 | |
| 6 | NVS |
Novartis AG
|
11,160 | $1,748,995 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,162 | $1,305,817 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
9,282 | $1,172,687 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,172,687 | 9,282 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,356,984 | 31,262 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,326,205 | 10,805 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,673,325 | 15,075 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,372,253 | 57,475 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,527,472 | 58,255 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,450,291 | 59,005 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,346,057 | 63,765 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,594,468 | 66,965 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,001,143 | 68,275 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,640,321 | 69,625 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,292,262 | 70,620 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,673,508 | 73,615 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,203,252 | 74,765 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,418,575 | 74,765 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,733,165 | 76,725 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,994,333 | 96,980 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,766,055 | 96,990 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,724,977 | 106,390 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,677,213 | 109,910 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,568,402 | 109,910 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,444,729 | 115,190 | Shares | Sole | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||